Cited 0 times in Scipus Cited Count

Treatment of indolent lymphoma

DC Field Value Language
dc.contributor.authorJeong, SH-
dc.date.accessioned2023-02-27T07:13:08Z-
dc.date.available2023-02-27T07:13:08Z-
dc.date.issued2022-
dc.identifier.issn2287-979X-
dc.identifier.urihttp://repository.ajou.ac.kr/handle/201003/24966-
dc.description.abstractTreatment of indolent lymphoma has improved significantly in recent decades since the advent of rituximab (anti-CD20 monoclonal antibody). Although, some patients with limited disease can be cured with radiation therapy alone, most patients experience disease progression and recurrence during follow-up despite early initiation of treatment. Thus, watch-and-wait is still regarded the standard for asymptomatic patients. Patients with indolent lymphoma have a significant heterogeneity in terms of tumor burden, symptoms (according to anatomical sites) and the need for instant therapy. Therefore, the initiation of treatment and treatment option should be decided with a clear goal in each patient according to the need for therapy and clinical benefits with the chosen treatment. In this review, we cover the current treatment of follicular lymphoma and marginal zone lymphoma.-
dc.language.isoen-
dc.titleTreatment of indolent lymphoma-
dc.typeArticle-
dc.identifier.pmid35483936-
dc.identifier.urlhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9057664-
dc.subject.keywordFollicular lymphoma-
dc.subject.keywordIndolent lymphoma-
dc.subject.keywordMarginal zone lymphoma-
dc.subject.keywordNon-Hodgkin’s lymphoma-
dc.contributor.affiliatedAuthorJeong, SH-
dc.type.localJournal Papers-
dc.identifier.doi10.5045/br.2022.2022054-
dc.citation.titleBlood research-
dc.citation.volume57-
dc.citation.numberS1-
dc.citation.date2022-
dc.citation.startPage120-
dc.citation.endPage129-
dc.identifier.bibliographicCitationBlood research, 57(S1). : 120-129, 2022-
dc.identifier.eissn2288-0011-
dc.relation.journalidJ02287979X-
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Hematology-Oncology
Files in This Item:
35483936.pdfDownload

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse